Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application

BACKGROUND: Doxorubicin (DOX) is one of the most potent antitumor agents available; however, its clinical use is limited because of the risk of severe cardiotoxicity. Though numerous studies have ascribed DOX cardiomyopathy to specific cellular pathways, the precise mechanism remains obscure. Sini d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Guangguo, Lou, Ziyang, Liao, Wenting, Zhu, Zhenyu, Dong, Xin, Zhang, Wei, Li, Wuhong, Chai, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218026/
https://www.ncbi.nlm.nih.gov/pubmed/22110719
http://dx.doi.org/10.1371/journal.pone.0027683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218026/
https://www.ncbi.nlm.nih.gov/pubmed/22110719
http://dx.doi.org/10.1371/journal.pone.0027683

Ejemplares similares